Loading page
Loading page
Loading substance route
Proscaline is not habit-forming, and the desire to use it can actually decrease with use. It is described as most often self-regulating.
The exact toxic dosage is unknown. Very little data exists about the toxicity of proscaline, and no lethal dose estimates have been established.
Proscaline was first synthesized and investigated by Czech chemist Otakar Leminger in 1972. The compound was subsequently synthesized by David E. Nichols, who published his work in the Journal of Medicinal Chemistry in 1977. Around this period, Alexander Shulgin independently explored the…
Regulated under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) since November 26, 2016. Production, import with intent to distribute, administration to others, and trading are criminal offenses. Possession itself is prohibited but not subject to criminal penalty, though ordering may be prosecuted as incitement to market the substance.
Controlled as a Class A substance under the Misuse of Drugs Act 1971 via the phenethylamine derivatives catch-all clause. Class A substances carry the most severe penalties under UK law.
Classified as a controlled substance under Verzeichnis E, point 130, as a defined derivative of phenethylamine. Exemptions exist for scientific research and industrial applications.
Not specifically scheduled under the Controlled Substances Act. However, sale for human consumption could potentially trigger prosecution under the Federal Analogue Act due to structural similarity to mescaline, a Schedule I substance.
13 sources cited